Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

Intensive Crisis Intervention for teens with suicidal thoughts or behaviors

Official title: Intensive Crisis Intervention (ICI) for Adolescent Suicidal Behavior

Run by Nationwide Children's Hospital · NCT06476886 · Data updated 2026-11-12

This project will try a brief, family-focused Intensive Crisis Intervention to see if it helps 12–17-year-olds with suicidal thoughts or recent attempts reduce suicidal behavior and avoid inpatient psychiatric care.

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment213 (estimated)
SponsorNationwide Children's Hospital
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedJune 3, 2024
Main results expectedDecember 31, 2026
Study endsJuly 31, 2027
Registry record updatedSeptember 21, 2026
Trial IDNCT06476886 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 12 years 0 months to 17 years 6 months presenting with suicidal ideation or behavior who are clinically eligible for both the YCSU and APIU, score ≥23 on the CHRT-SR, and have a legal guardian able to consent are the intended participants.

Probably not a fit

Patients who are actively psychotic, unable to understand study procedures (for example due to significant intellectual disability), unable to read or speak English sufficiently, or not eligible for admission to both care settings are unlikely to benefit from this intervention as tested.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project refines and pilots Intensive Crisis Intervention (ICI), a brief treatment that blends family therapy/parent training, cognitive behavioral therapy, and motivational interviewing to target family functioning and reduce adolescent suicidal behavior. In Year 1 the team will develop a treatment manual, training and supervision protocols, and data collection procedures, then pilot ICI with about 20 adolescents, 20 parents, and 16 providers. After refinement, 60 youths aged 12–17 presenting with suicidal ideation or behavior and eligible for both the Youth Crisis Stabilization Unit (YCSU) and an adolescent psychiatric inpatient unit (APIU) will be randomized 1:1 to receive ICI in the YCSU (n=30) or standard inpatient care in the APIU (n=30). A mixed-methods approach will examine feasibility, acceptability, implementation processes, and preliminary clinical and service-use outcomes at Nationwide Children's Hospital.

Why it matters

Potential benefit: If successful, ICI could offer a shorter, family-centered alternative that reduces inpatient admissions and improves family functioning and suicidal outcomes for adolescents.

How similar studies have gone: Components of ICI such as family therapy, cognitive behavioral therapy, and motivational interviewing have shown promise for adolescent suicidality, but the combined brief ICI package and its implementation in a crisis stabilization unit is novel and not yet fully tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Youth between the ages of 12 years 0 months and 17 years 6 months at time of consent
2. Present to the Nationwide Children's Hospital (NCH) Psychiatric Crisis Department (PCD) or NCH Psychiatry Consult Liaison (CL) Service with suicidal ideation and/or behavior as the primary referral
3. Be eligible for admission to both YCSU and APIU based on PCD or CL clinician's clinical judgement
4. Patient and legal guardian must be willing to be admitted to either YCSU or APIU
5. Youth obtains a score of ≥23 on the Concise Health Risk Tracking Self-Report (CHRT-SR)
6. Youth resides with a primary caretaker who has legal authority to consent for participation in research
7. Legal guardian must attend the PCD or CL evaluation

Exclusion Criteria:

1. Participants who are unable to understand study procedures (e.g., intellectual disability, actively psychotic)
2. Inability to speak or read English adequately to understand and complete study consent and procedures

YCSU clinicians, PCD staff, and NCH-BH leaders will be invited to participate based on their roles in the system-of-care.

Where it's running

  • Nationwide Children's Hospital
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Testing a mobile app to help prevent suicide

    This study is testing a new mobile app designed to help young adults who have had suicidal thoughts or behaviors in the past month to see if it can prevent suicide.

    Recruiting Butler Hospital · Providence, Rhode Island · NCT05180344

  • Enhanced Outreach After ED Visit to Prevent Suicide Attempts

    This study tests a weekly outreach program by a crisis organization after an ED visit for suicidal thoughts to see if it’s doable and helpful for participants.

    Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT05825820

  • New treatment method for reducing suicidality after a crisis

    This study is testing a new short-term treatment for people who have recently tried to harm themselves to see if it can help reduce feelings of hopelessness and improve support from family and friends.

    Recruiting at 12 sites University Hospital, Ghent · Beernem and 11 other locations · NCT05638204

  • Improving suicide prevention strategies for teens

    This study is testing two new ways to help teens aged 11-17 who are at risk of suicide to see if they work better than regular care.

    Recruiting at 2 sites Seattle Children's Hospital · Columbus, Ohio and 1 other locations · NCT05078970

  • Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression

    This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.

    Recruiting Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Madrid, Madrid · NCT07885722

  • Inhaled DMT for major depressive disorder

    This trial tests whether inhaled DMT can quickly ease depressive symptoms and reduce suicide risk in adults with major depressive disorder.

    Recruiting Phase 2 Universidade Federal do Rio Grande do Norte · Fortaleza, Ceará and 4 other locations · NCT07562191

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.